Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients

Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients

Guardado en:
Detalles Bibliográficos
Autor principal: Shunguo Zhang MB
Formato: article
Lenguaje:EN
Publicado: SAGE Publishing 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/d4a329a83c7b44f78e8e40ea829ff437
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d4a329a83c7b44f78e8e40ea829ff437
record_format dspace
spelling oai:doaj.org-article:d4a329a83c7b44f78e8e40ea829ff4372021-11-05T22:33:49ZAuthor Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients1533-033810.1177/15330338211049894https://doaj.org/article/d4a329a83c7b44f78e8e40ea829ff4372021-10-01T00:00:00Zhttps://doi.org/10.1177/15330338211049894https://doaj.org/toc/1533-0338Shunguo Zhang MBSAGE PublishingarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENTechnology in Cancer Research & Treatment, Vol 20 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Shunguo Zhang MB
Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
format article
author Shunguo Zhang MB
author_facet Shunguo Zhang MB
author_sort Shunguo Zhang MB
title Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
title_short Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
title_full Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
title_fullStr Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
title_full_unstemmed Author Response: Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients
title_sort author response: correlation of l-asp activity, anti-l-asp antibody, asn and gln with adverse events especially anaphylaxis risks in peg-asp-contained regime treated pediatric all patients
publisher SAGE Publishing
publishDate 2021
url https://doaj.org/article/d4a329a83c7b44f78e8e40ea829ff437
work_keys_str_mv AT shunguozhangmb authorresponsecorrelationoflaspactivityantilaspantibodyasnandglnwithadverseeventsespeciallyanaphylaxisrisksinpegaspcontainedregimetreatedpediatricallpatients
_version_ 1718444010921525248

Ejemplares similares